We have seen an unprecedented rise in NYSE:ACB in the past days (216% since Thursday 5/14). This made the stock be close to the higher limit of top analysts targets. If we take a closer look into the ACB's fundamentals and financial conditions, we expect the stock to go short in the next months. There is low support for such a high rise at the moment, as the stock is at highest levels since February, on the other side there are signs the current valuation is over the realistic financial conditions.
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp-related food products.
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp-related food products.